Publication | Open Access

The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer

MedicineBronchial NeoplasmPharmacotherapyCancer TreatmentSecond-line TherapyOncologyRadiation OncologyCancer ChemotherapyLung CancerInduction Chemotherapy